Development of Technetium and Rhenium Radiopharmaceuticals for Theranostic Targeting of Cancer Receptors

Date: 
Tuesday, February 12, 2019 12:00 pm
Location: 
103 Schlundt
Event Type: 
Speaker: 
Heather Hennkens
Affiliation: 
MURR
Host: 
Lever